CCK
-
Proglumide
Catalog No. A18171 CCK antagonistProglumide is a drug that exerts an inhibitory effect on gastric secretion and reduces gastrointestinal motility. IProglumide is a known cholecystokinin (CCK) antagonist. 了解更多 -
Dexloxiglumide
Catalog No. A18541 CCKA receptor antagonistDexloxiglumide is a selective cholecystokinin type A (CCKA) receptor antagonist. Dexloxiglumide, the active enantiomer of Loxiglumide, inhibits smooth muscle cell contractions induced by cholecystokinin-octapeptide (CCK-8). 了解更多 -
Loxiglumide (CR1505)
Catalog No. A11769 -
Proglumide sodium salt
Catalog No. A13713 CCK 拮抗剂Proglumide sodium salt是一种非选择性胆囊收缩素(CCK)拮抗剂。它抑制CCK刺激的淀粉酶分泌,并防止CCK诱导的小鼠胰腺腺泡中的2-脱氧葡萄糖摄取。 了解更多 -
Z-360 calcium salt (Nastorazepide calcium salt)
Catalog No. A13671 CCK-2 receptor 拮抗剂Z-360 calcium salt (Nastorazepide calcium salt)是一种选择性口服可口服的1,5-苯并二氮杂卓衍生物胃泌素/胆囊收缩素2(CCK-2)受体拮抗剂,具有潜在的抗肿瘤活性。 了解更多 -
Nastorazepide (Z-360)
Catalog No. A15984 CCK-2 receptor 拮抗剂Nastorazepide (Z-360) 是一种选择性的,口服的1,5-苯二氮杂卓衍生物胃泌素/胆囊收缩素2(CCK-2)受体拮抗剂,具有潜在的抗肿瘤活性。 了解更多